Collaborating on biomanufacturing capacity

Addressing the need for flexible manufacturing options aligned with your business strategy

Balancing risk and speed

Development of emerging and novel therapies is moving faster than ever. To keep pace among uncertainties about future manufacturing timing and scale, you need to weigh options. We know that with emerging therapies, one size doesn’t fit all. Boost your in-house expertise through collaboration to assess options that can offer flexibility in your process and manufacturing strategy.

Staying flexible in biomanufacturing can help you manage unknowns.

Build or buy   |    Manufacturing resources    |    Facility solutions

 

Build or buy manufacturing capacity

Whether you’re waiting for a production slot with a qualified CDMO or ready to build, a flexible strategy can help you scale quickly, to produce the right quantity at the right time. The decision to build, buy, or both requires a careful assessment of many factors. READ MORE

How to rapidly create single-use biomanufacturing capacity.

On-demand webinar: Outsourcing to accelerate your next milestone.

 

Manufacturing resources

HB Card image - Viral vector facilities

Viral vector manufacturing shortage

Address the gap by understanding available strategies and how to select the most cost-effective solution.

The industrial internet of things is transforming biomanufacturing

Preparing for the future of biomanufacturing

New market dynamics are reshaping how biologics are produced and sold. Here’s what six industry experts say about the way forward.

right_type_of_capacity_v2

Determining the right type of capacity

A flexible strategy can help you produce smaller scale, more potent molecules while supporting manufacturing of multiple products.

CDMO checklist

Expert insights on outsourcing

Choose a CDMO wisely to accelerate your programs while managing risk.

Mapping roads of the future

Mapping roads to the future

Explore available options to select a path based on molecule and facility fit needs.

Doubling up for speed

Doubling up for speed in biomanufacturing

Parallel operations afford the opportunity to develop a process in a parallel path using the resources of an external CDMO partner.

 

Facility solutions

Manufacturing cell and gen therapy

Manufacturing cell and gene therapies

Services and manufacturing solutions for scalable and efficient end-to-end production.

End to end bioprocessing

End to end bioprocessing

Meet changing market demands with flexible solutions to help manage process complexity.

vector manufacturing image

Vector manufacturing

Rapidly add capacity and retain flexibility with modular end-to-end options.

Fast track biomanufacturing services

Fast Trak Biomanufacturing Services

Biologics contract development and manufacturing organization (CDMO).

Worldwide reach app web image

Case studies

From feasibility to biomanufacturing facility.